Researchers Find Neuro Biomarkers to Create Smart Brain Stimulators for Parkinson Treatment

Parkinson's disease is a progressive nervous system disorder that affects movement.

Image credit: University of Houston

Parkinson's disease is a progressive nervous system disorder that affects movement. Symptoms include muscle rigidity, tremors, and changes in speech and gait. After diagnosis, treatments can help relieve symptoms, but there is no cure.

Related Abbott, Medtronic Driving Deep Brain Stimulation Innovation for Parkinson’s Disease

The established treatment for this condition is high-frequency brain stimulation. However, the therapy is imprecise because stimulators can only be programmed clinically and are not adaptable to the fluctuating symptoms of the disease. The key to improving the technology is biomarkers.

Now, researchers at the University of Houston have found neuro biomarkers for Parkinson’s disease that can help create the next generation of “smart” deep brain stimulators, able to respond to specific needs of Parkinson’s disease patients, reports Laurie Fickman of University of Houston.

“We can now make the closed-loop stimulator adaptive to sense a patient’s symptoms, so it can make the adjustments to the fluctuations in real time, and the patient no longer has to wait for weeks or months until the doctor can adjust the device,” said Nuri Ince, associate professor of biomedical engineering. He and doctoral student Musa Ozturk, lead author of the paper, published their findings in Movement Disorders journal.

Ezekiel W. Cullen Building, University of Houston (Image: Wikimedia commons)

The researchers also report a new understanding of the electrophysiology of Parkinson’s disease after examining cross frequency coupling in the subthalamic nucleus of patients with Parkinson’s disease both in the OFF state (before medication) and the ON state (after medication). Coupling, the interaction between the brain waves, has been reported in the past, but its significance and functional role have not been well understood.

Related Graphene to Protect Implantable Neurostimulators in People with Neurological Disorders

“Previous research showed coupling only existed in the basal ganglia of untreated patients and assumed to block the brain from functioning properly,” said Ozturk. “We found that strong coupling also exists in treated patients, though at different frequencies, so in effect we have ‘cleared coupling’s name’ and showed the frequencies involved in coupling impacts whether its effects are negative or positive.”

Sam Draper
August 6, 2019

Innovation of the Month

Do you want to discover more, visit the website
Visit Website

Other news

Withings Buys Leading Health and Fitness App 8Fit To Boost Health Insights

Withings, a health tech company, announced the acquisition of 8fit, a worldwide health, fitness,...

Sony Debuts New Wearable with B-to-B Mobile Health Platform

Electronics giant Sony has launched its new mSafety mobile health platform...

Partnership to Launch AI-Powered Avatar Generation Tool

Krikey.ai partnered up with Stability AI to launch an animation tool.

Brilliantly Warm: First-Ever Wearable for Women Who’ve Had Breast Reconstruction Surgery

Brilliantly Warm, the first-ever wearable for women who have had breast reconstruction surgery ...
Discover more